Belviq is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lorcaserin Hydrochloride Hemihydrate.
| Product ID | 62856-529_3097271d-6dae-4dce-91c2-783e31678eb6 | 
| NDC | 62856-529 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Belviq | 
| Generic Name | Lorcaserin Hydrochloride Hemihydrate | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2012-06-27 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA022529 | 
| Labeler Name | Eisai Inc. | 
| Substance Name | LORCASERIN HYDROCHLORIDE HEMIHYDRATE | 
| Active Ingredient Strength | 10 mg/1 | 
| Pharm Classes | Serotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] | 
| DEA Schedule | CIV | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2012-06-27 | 
| Marketing End Date | 2022-04-30 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA022529 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2012-06-27 | 
| Ingredient | Strength | 
|---|---|
| LORCASERIN HYDROCHLORIDE HEMIHYDRATE | 10 mg/1 | 
| SPL SET ID: | 7cbbb12f-760d-487d-b789-ae2d52a3e01f | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 62856-529 | Belviq | lorcaserin hydrochloride hemihydrate | 
| 62856-535 | BELVIQ XR | lorcaserin hydrochloride hemihydrate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  BELVIQ  85962041  4550429 Live/Registered | Arena Pharmaceuticals GmbH 2013-06-17 | 
|  BELVIQ  85714025  4599551 Live/Registered | EISAI INC. 2012-08-27 | 
|  BELVIQ  85714013  4415887 Live/Registered | EISAI INC. 2012-08-27 | 
|  BELVIQ  85660690  4415734 Live/Registered | EISAI INC. 2012-06-25 | 
|  BELVIQ  85660637  4639221 Live/Registered | Arena Pharmaceuticals GmbH 2012-06-25 | 
|  BELVIQ  85660483  4599534 Live/Registered | EISAI INC. 2012-06-25 | 
|  BELVIQ  85354490  4080253 Live/Registered | EISAI INC. 2011-06-23 |